newsfilter
← Latest News
GlobeNewswire·

MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

ROCKVILLE, Md., Aug. 06, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and